bibliographic entry 12437352 [be/12437352]
https://w3id.org/oc/corpus/be/12437352

is a
content
  • Gandhi, L, Camidge, D.R, de Oliveira, M.R, Bonomi, P, Gandara, D, Khaira, D, Hann, C.L, McKeegan, E.M, Litvinovich, E, Hemken, P.M. Phase I study of navitoclax (ABT-263), a novel Bcl-2 family inhibitor, in patients with small-cell lung cancer and other solid tumors, J. Clin. Oncol, 2011, 29, 909, 916, DOI: 10.1200/JCO.2010.31.6208, PMID: 21282543
references